Dopaminergic function and intertemporal choice

Translational Psychiatry

Volumn 5, Issue 1, 2015, Pages

  Joutsa, J ^a   Voon, V ^b   Johansson, J ^a   Niemela S ^c   Bergman, J ^a   Kaasinen, V ^a,d  

^a TURKU PET CENTRE   (Finland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OULU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; RACLOPRIDE C 11; ANTIPARKINSON AGENT; DOPA; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; RACLOPRIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DECISION MAKING; DELAY DISCOUNTING; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; HUMAN; NUCLEUS ACCUMBENS; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; RECEPTOR DENSITY; ADDICTION; AGED; ANALOGS AND DERIVATIVES; BRAIN; CASE CONTROL STUDY; CAUDATE NUCLEUS; CHEMICALLY INDUCED; GAMBLING; MALE; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; PSYCHOLOGY; SCINTISCANNING; SYNAPTIC TRANSMISSION; VENTRAL STRIATUM; YOUNG ADULT;

ADULT; AGED; ANTIPARKINSON AGENTS; BEHAVIOR, ADDICTIVE; BRAIN; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; DELAY DISCOUNTING; DIHYDROXYPHENYLALANINE; DOPAMINE; DOPAMINE ANTAGONISTS; GAMBLING; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE; SYNAPTIC TRANSMISSION; VENTRAL STRIATUM; YOUNG ADULT;

EID: 84927919612     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.133     Document Type: Article

References (55)

1. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999; 128: 78-87
2. Bickel WK, Koffarnus MN, Moody L, Wilson AG. The behavioral-and neuroeconomic process of temporal discounting: A candidate behavioral marker of addiction. Neuropharmacology 2013; 76: 518-527
3. Diergaarde L, Pattij T, Poortvliet I, Hogenboom F, de Vries W, Schoffelmeer AN et al. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 2008; 63: 301-308
4. Perry JL, Nelson SE, Carroll ME. Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 2008; 16: 165-177
5. Broos N, Diergaarde L, Schoffelmeer AN, Pattij T, De Vries TJ. Trait impulsive choice predicts resistance to extinction and propensity to relapse to cocaine seeking: A bidirectional investigation. Neuropsychopharmacology 2012; 37: 1377-1386
6. Milenkova M, Mohammadi B, Kollewe K, Schrader C, Fellbrich A, Wittfoth M et al. Intertemporal choice in Parkinson's disease. Mov Disord 2011; 26: 2004-2010
7. Voon V, Dalley JW. Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy. Nat Rev Neurol 2011; 7: 541-542
8. Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010; 207: 645-659
9. Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsivecompulsive spectrum behaviors. Neuropsychopharmacology 2010; 35: 2155-2164
10. Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R et al. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease. J Neuropsychol 2013; 7: 306-325
11. Kobayashi S, Schultz W. Influence of reward delays on responses of dopamine neurons. J Neurosci 2008; 28: 7837-7846
12. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001; 292: 2499-2501
13. Floresco SB, Tse MT, Ghods-Sharifi S. Dopaminergic and glutamatergic regulation of effort-and delay-based decision making. Neuropsychopharmacology 2008; 33: 1966-1979
14. Richards JB, Sabol KE, de Wit H. Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 1999; 146: 432-439
15. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 2006; 60: 66-73
16. Roesch MR, Takahashi Y, Gugsa N, Bissonette GB, Schoenbaum G. Previous cocaine exposure makes rats hypersensitive to both delay and reward magnitude. J Neurosci 2007; 27: 245-250
17. Pine A, Shiner T, Seymour B, Dolan RJ. Dopamine, time, and impulsivity in humans. J Neurosci 2010; 30: 8888-8896
18. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003; 41: 1431-1441
19. Kayser AS, Allen DC, Navarro-Cebrian A, Mitchell JM, Fields HL. Dopamine, corticostriatal connectivity, and intertemporal choice. J Neurosci 2012; 32: 9402-9409
20. Joutsa J, Johansson J, Niemelä S, Ollikainen A, Hirvonen MM, Piepponen P et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 2012; 60: 1992-1999
21. Linnet J, Peterson E, Doudet DJ, Gjedde A, Møller A. Dopamine release in ventral striatum of pathological gamblers losing money. Acta Psychiatr Scand 2010; 122: 326-333
22. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain 2009; 132: 1376-1385
23. O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011; 134: 969-978
24. Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiol Dis 2010; 39: 98-104
25. Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA et al. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry 2013; 85: 148-152
26. Joutsa J, Martikainen K, Niemelä S, Johansson J, Forsback S, Rinne JO et al. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord 2012; 27: 778-782
27. Robinson ES, Eagle DM, Economidou D, Theobald DE, Mar AC, Murphy ER et al. Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav Brain Res 2009; 196: 310-316
28. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007; 315: 1267-1270
29. Brown WD, Taylor MD, Roberts AD, Oakes TR, Schueller MJ, Holden JE et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology 1999; 53: 1212-1218
30. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752
31. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64: 1089-1096
32. Kirby KN, Petry NM. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004; 99: 461-471
33. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034-1057
34. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5: 584-590
35. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4: 153-158
36. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 2000; 20: 423-451
37. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 2001; 110: 482-487
38. Clark L, Stokes PR, Wu K, Michalczuk R, Benecke A, Watson BJ et al. Striatal dopamine D(2)/D(3) receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 2012; 63: 40-46
39. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al. Dopaminergic network differences in human impulsivity. Science 2010; 329: 532
40. Pine A, Seymour B, Roiser JP, Bossaerts P, Friston KJ, Curran HV et al. Encoding of marginal utility across time in the human brain. J Neurosci 2009; 29: 9575-9581
41. Cardinal RN, Winstanley CA, Robbins TW, Everitt BJ. Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci 2004; 1021: 33-50
42. Winstanley CA, Theobald DE, Cardinal RN, Robbins TW. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 2004; 24: 4718-4722
43. Ballard K, Knutson B. Dissociable neural representations of future reward magnitude and delay during temporal discounting. Neuroimage 2009; 45: 143-150
44. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci 2004; 7: 887-893
45. Kable JW, Glimcher PW. The neural correlates of subjective value during intertemporal choice. Nat Neurosci 2007; 10: 1625-1633
46. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science 2004; 306: 503-507
47. McClure SM, Ericson KM, Laibson DI, Loewenstein G, Cohen JD. Time discounting for primary rewards. J Neurosci 2007; 27: 5796-5804
48. Onoda K, Okamoto Y, Kunisato Y, Aoyama S, Shishida K, Okada G et al. Interindividual discount factor differences in reward prediction are topographically associated with caudate activation. Exp Brain Res 2011; 212: 593-601
49. Wittmann M, Leland DS, Paulus MP. Time and decision making: differential contribution of the posterior insular cortex and the striatum during a delay discounting task. Exp Brain Res 2007; 179: 643-653
50. Antonelli F, Ko JH, Miyasaki J, Lang AE, Houle S, Valzania F et al. Dopamineagonists and impulsivity in Parkinson's disease: impulsive choices vs impulsive actions. Hum Brain Mapp 2014; 35: 2499-2506
51. Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 2010; 20: 1175-1186
52. Figner B, Knoch D, Johnson EJ, Krosch AR, Lisanby SH, Fehr E et al. Lateral prefrontal cortex and self-control in intertemporal choice. Nat Neurosci 2010; 13: 538-539
53. Sheffer CE, Mennemeier M, Landes RD, Bickel WK, Brackman S, Dornhoffer J et al. Neuromodulation of delay discounting, the reflection effect, and cigarette consumption. J Subst Abuse Treat 2013; 45: 206-214
54. Pogarell O, Koch W, Popperl G, Tatsch K, Jakob F, Zwanzger P et al. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res 2006; 40: 307-314
55. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21: RC157.